OMCL250117C65000
- 0.40
- 0.000.00%
Omnicell Newsroom
How Humanoid Robots and AI Will Change the Workforce
Here's Why You Should Add HAE Stock to Your Portfolio Now
Tesla's Optimus is driving a transformation in the Industry, leading humanoid robots into a new era of mass production.
From 0 to 1, humanoid robots are about to enter mass production, and the Industry Chain will embrace investment opportunities.
Omnicell's SWOT Analysis: Healthcare Tech Firm's Stock Faces Growth Hurdles
Omnicell Insider Sold Shares Worth $567,638, According to a Recent SEC Filing
What Makes Omnicell (OMCL) a New Strong Buy Stock
Omnicell Introduces OmniSphere Platform, Stock to Gain
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $54
Omnicell Announces OmniSphere, A Next-Generation, Cloud Native, Software Workflow Engine And Data Platform
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Raises Target Price to $69
The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health
Will HAE Stock Gain Following Sell-Off of Whole Blood Assets to GVS?
LSPedia AND OMNICELL COLLABORATE IN AN EFFORT TO ADVANCE PHARMACY SUPPLY CHAIN COMPLIANCE AND INNOVATION FOR HOSPITALS AND HEALTH SYSTEMS
Wells Fargo Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $49
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?
Should You Investigate Omnicell, Inc. (NASDAQ:OMCL) At US$48.46?
Calculating The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference
Colliers Securities Initiates Omnicell(OMCL.US) With Buy Rating, Announces Target Price $52
Beyond The Numbers: 6 Analysts Discuss Omnicell Stock